The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
Open accessAbstract
Neuroinflammation has been identified as a causative factor of multiple neurological diseases. The nucleotide-binding oligomerization domain-, leucine-rich repeat- and pyrin domain-containing 3 (NLRP3) inflammasome, a subcellular multiprotein complex that is abundantly expressed in the central nervous system (CNS), can sense and be activated by a wide range of exogenous and endogenous stimuli such as microbes, aggregated and misfolded proteins, and adenosine triphosphate, which results in activation of caspase-1. Activated caspase-1 subsequently leads to the processing of interleukin-1β (IL-1β) and interleukin-18 (IL-18) pro-inflammatory cytokines and mediates rapid cell death. IL-1β and IL-18 drive inflammatory responses through diverse downstream signaling pathways, leading to neuronal damage. Thus, the NLRP3 inflammasome is considered a key contributor to the development of neuroinflammation. In this review article, we briefly discuss the structure and activation the NLRP3 inflammasome and address the involvement of the NLRP3 inflammasome in several neurological disorders, such as brain infection, acute brain injury and neurodegenerative diseases. In addition, we review a series of promising therapeutic approaches that target the NLRP3 inflammasome signaling including anti-IL-1 therapy, small molecule NLRP3 inhibitors and other compounds, however, these approaches are still experimental in neurological diseases. At present, it is plausible to generate cell-specific conditional NLRP3 knockout (KO) mice via the Cre system to investigate the role of the NLRP3 inflammasome, which may be instrumental in the development of novel pharmacologic investigations for neuroinflammation-associated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It triggers pyroptotic cell death in microglia and astrocytes by producing IL-1β and IL-18 pro-inflammatory cytokines.298”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [298]
In the citing paper
“Besides, NLRP3 inflammasome is probably involved in neuroinflammation in MSA.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [298]
In the citing paper
“Inflammasome products are targets of several therapies used to treat some of the disorders that we have presented here (256).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [256]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Héry-Arnaud, G., Berre, R. L., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 5,008
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,444
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Pyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,288
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2016) · Nature · doi:10.1038/nature18629 · Cited by 3,202
Flagged first, then by citations
Research works printed but not linked: 1
- Becher, 2000, Brain-immune connection: immuno-regulatory properties of CNS-resident cells, Glia, 29, 293, 10.1002/(SICI)1098-1136(20000215)29:4293::AID-GLIA13.3.CO;2-1 · DOI
Cited by
Sorted by citations
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821
Role of the NLRP3 inflammasome in cancer
Moossavi, M., Parsamanesh, N., Bahrami, A., Atkin, S. L., & Sahebkar, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0900-3 · Cited by 431
Kempuraj, D., Thangavel, R., Selvakumar, G. P., Zaheer, S. A., Ahmed, M. E., Raikwar, S. P., Zahoor, H., Saeed, D., Natteru, P., Iyer, S. S., et al. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00216 · Cited by 382
Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome
Tejera, D., Mercan, D., Sanchez‐Caro, J. M., Hanan, M., Greenberg, D., Soreq, H., Latz, E., Golenbock, D., & Heneka, M. T. (2019) · The EMBO Journal · doi:10.15252/embj.2018101064 · Cited by 351
Zhang, Y., Huang, R., Cheng, M., Wang, L., Chao, J., Li, J., Zheng, P., Xie, P., Zhang, Z., & Yao, H. (2019) · Microbiome · doi:10.1186/s40168-019-0733-3 · Cited by 263
Moonen, S., Koper, M. J., Schoor, E. V., Schaeverbeke, J. M., Vandenberghe, R. R., Arnim, C. A. F. V., Tousseyn, T., Strooper, B. D., & Thal, D. R. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02528-y · Cited by 268
Mehto, S., Jena, K. K., Nath, P., Chauhan, S., Kolapalli, S. P., Das, S. K., Sahoo, P. K., Jain, A., Taylor, G. A., & Chauhan, S. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.018 · Cited by 238
Mitochondrial dysfunction in the development and progression of neurodegenerative diseases
Johnson, J., Mercado‐Ayón, E., Mercado-Ayon, Y., Dong, Y., Halawani, S. M., Ngaba, L. V., & Lynch, D. R. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108698 · Cited by 254
The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins
Deora, V., Lee, J. D., Albornoz, E. A., McAlary, L., Jagaraj, C. J., Robertson, A. A. B., Atkin, J. D., Cooper, M. A., Schroder, K., Yerbury, J. J., et al. (2020) · Glia · doi:10.1002/glia.23728 · Cited by 245
Xu, X. J., Yin, D., Ren, H., Gao, W., Li, F., Sun, D., Wu, Y., Zhou, S., Lyu, L., Yang, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.016 · Cited by 240
Self-citationThe NLRP3 Inflammasome and Its Role in Sepsis Development
Danielski, L. G., Giustina, A. D., Bonfante, S., Barichello, T., & Petronilho, F. C. (2019) · Inflammation · doi:10.1007/s10753-019-01124-9 · Cited by 237
Role of pyroptosis in spinal cord injury and its therapeutic implications
Mamun, A. A., Wu, Y., Monalisa, I., Jia, C., Zhou, K., Munir, F., & Xiao, J. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.08.004 · Cited by 232
Self-citationMicroglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice
Li, S., Fang, Y., Zhang, Y., Song, M., Zhang, X., Ding, X., Yao, H., Chen, M., Sun, Y., Ding, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111532 · Cited by 225
Ahmed, S., Kwatra, M., Panda, S. R., Murty, U. S. N., & Naidu, V. G. M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.017 · Cited by 217
Microglia and Neuroinflammation: What Place for P2RY12?
Gómez Morillas, A., Besson, V. C., & Lerouet, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041636 · Cited by 214
Mishra, S. R., Mahapatra, K. K., Behera, B. P., Patra, S., Bhol, C. S., Panigrahi, D. P., Praharaj, P. P., Singh, A., Patil, S., Dhiman, R., et al. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106013 · Cited by 195
Wu, A., Zhou, X., Qiao, G., Yu, L., Tang, Y., Yan, L., Qiu, W., Pan, R., Yu, C., Law, B. Y. K., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101202 · Cited by 196
Hou, B., Zhang, Y., Liang, P., He, Y., Peng, B., Liu, W., Han, S., Yin, J., & He, X. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2565-2 · Cited by 187
Neuron-Astrocyte Interactions in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2020) · Cells · doi:10.3390/cells9122623 · Cited by 186
The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101192 · Cited by 186
Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia
Liu, Y., Dai, Y., Li, Q., Chen, C., Chen, H., Song, Y., Hua, F., & Zhang, Z. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135279 · Cited by 183
Zhu, J., Hu, Z., Han, X., Wang, D., Jiang, Q., Ding, J., Xiao, M., Wang, C., Lu, M., & Hu, G. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0127-2 · Cited by 179
Zeller, M. V., Dias, D., Sebastião, A. M., & Valente, C. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210268 · Cited by 179
Lau, V. Z., Ramer, L. M., & Tremblay, M. (2023) · Nature Communications · doi:10.1038/s41467-023-37304-3 · Cited by 175
Sun, Y., Zhao, H., Mu, D.-L., Zhang, W., Jiang, C., Wu, L., Alam, A., Wang, D., & Ma, D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1416-5 · Cited by 170
Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
Mamik, M. K., & Power, C. (2017) · Brain · doi:10.1093/brain/awx133 · Cited by 169
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Diz-Chaves, Y., Mastoor, Z., Spuch, C., González-Matías, L. C., & Mallo, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179583 · Cited by 148
Laurindo, L. F., Dias, J. A., Araújo, A. C., Pomini, K. T., Galhardi, C. M., Detregiachi, C. R. P., Haber, L. S. D. A., Roque, D. D., Bechara, M. D., de Castro, M. V. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305933 · Cited by 156
Diet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 150
Ren, B., Feng, J., Yang, N., Guo, Y., Chen, C., & Qin, Q. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107841 · Cited by 145
An Integrative Approach to Neuroinflammation in Psychiatric disorders and Neuropathic Pain
Lurie, D. I. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518793639 · Cited by 152
NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology
He, X., Yang, W., Zeng, Z., Wei, Y., Gao, J., Zhang, B., Li, L., Liu, L., Wan, Y., Zeng, Q., et al. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0260-y · Cited by 140
New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation
Kodi, T., Sankhe, R., Gopinathan, A., Nandakumar, K., & Kishore, A. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10101-5 · Cited by 157
Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
Lardenoije, R., Roubroeks, J. A. Y., Pishva, E., Leber, M., Wagner, H., Iatrou, A., Smith, A. R., Smith, R. G., Eijssen, L., Kleineidam, L., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0755-5 · Cited by 135
Inflammasome biology, molecular pathology and therapeutic implications
Awad, F., Assrawi, E., Louvrier, C., Jumeau, C., Georgin‐Lavialle, S., Grateau, G., Amselem, S., Giurgea, I., & Karabina, S. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.011 · Cited by 138
Wang, B., Shi, J., Ge, N.-N., Ou, Z., Tian, Y., Jiang, T., Zhou, J., Xu, J. L., & Zhang, Y.-D. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1178-5 · Cited by 133
Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
Morris, G., Walker, A. J., Berk, M., Maes, M. H. J., & Puri, B. K. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0793-y · Cited by 134
Zou, P. F., Liu, X., Li, G., & Wang, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8241 · Cited by 130
RetractedHigh Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy
Ravizza, T., Terrone, G., Salamone, A., Frigerio, F., Balosso, S., Antoine, D. J., & Vezzani, A. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.008 · Cited by 129
Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
Craig, C. F., Filippone, R. T., Stavely, R., Bornstein, J. C., Apostolopoulos, V., & Nurgali, K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02354-1 · Cited by 124
Jiao, J., Zhao, G., Wang, Y., Ren, P., & Wu, M. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00037 · Cited by 124
A review of the pharmacology and toxicology of aucubin
Zeng, X., Guo, F., & Ouyang, D. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.104443 · Cited by 119
Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice
Tian, H., Lu, X., Shi, J., Liu, X., Chen, Q., Wang, Q., Chen, Y., & Zhang, S. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15026 · Cited by 119
He, X., Li, L., Xian, W., Li, M., Zhang, L., Xu, J., Pei, Z., Zheng, H., & Hu, X. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02199-8 · Cited by 116
Lee, S. W., Vaccari, J. P. D. R., Truettner, J. S., Dietrich, W. D., & Keane, R. W. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1423-6 · Cited by 115
Gallagher, E. R., & Holzbaur, E. L. F. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112037 · Cited by 111
Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression
Zhang, Q., Sun, Y., He, Z., Xu, Y. X., Li, X., Ding, J., Lu, M., & Hu, G. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.016 · Cited by 111
Kronman, H., Torres-Berrío, A., Sidoli, S., Issler, O., Godino, A., Ramakrishnan, A., Mews, P., Lardner, C. K., Parise, E. M., Walker, D. M., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00814-8 · Cited by 108
Mugisho, O. O., Green, C. R., Kho, D. T., Zhang, J., Graham, E. S., Acosta, M. L., & Rupenthal, I. D. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.11.015 · Cited by 108
Li, M., Hua, Q., Shao, Y., Zeng, H., Liu, Y., Diao, Q., Zhang, H., Qiu, M., Zhu, J., Li, X., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.105976 · Cited by 110
Ye, T., Meng, X., Wang, R., Zhang, C., He, S., Sun, G., & Sun, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123977 · Cited by 104
Pellegrini, C., Fornai, M., Antonioli, L., Blandizzi, C., & Calderone, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122876 · Cited by 113
Inflammatory Cascade in Alzheimer’s Disease Pathogenesis: A Review of Experimental Findings
de Oliveira, J., Kucharska, E., Garcez, M. L., Rodrigues, M. S., Quevedo, J., Moreno‐González, I., & Budni, J. (2021) · Cells · doi:10.3390/cells10102581 · Cited by 110
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
Shao, B., Cao, Q., & Chong, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00320 · Cited by 103
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
Santarpía, M., Aguilar, A., CHAIB-OUKADOUR, I., Cardona, A. F., Fancelli, S., Laguía, F., Bracht, J. W. P., Cao, P., Molina‐Vila, M. Á., Karachaliou, N., et al. (2020) · Cancers · doi:10.3390/cancers12061475 · Cited by 102
The Role of TDP-43 in Neurodegenerative Disease
Liao, Y.-Z., Ma, J., & Dou, J.-Z. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02847-x · Cited by 110
Chai, Y., Cai, Y., Fu, Y., Wang, Y., Zhang, Y., Zhang, X., Zhu, L., Miao, M., & Yan, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.812362 · Cited by 104
Mitochondrial dysfunction in astrocytes: A role in Parkinson’s disease?
Bantle, C. M., Hirst, W. D., Weihofen, A., & Shlevkov, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.608026 · Cited by 95
Neuroinflammation in Sepsis: Molecular Pathways of Microglia Activation
Moraes, C. A., Zaverucha-do-Valle, C., Fleurance, R., Sharshar, T., Bozza, F. A., & d’Avila, J. C. (2021) · Pharmaceuticals · doi:10.3390/ph14050416 · Cited by 105
Role of pyroptosis in the pathogenesis of various neurological diseases
Oladapo, A., Jackson, T., Menolascino, J., & Periyasamy, P. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.001 · Cited by 101
Chen, Y., Meng, J., Xu, Q., Long, T., Bi, F., Chang, C., & Liu, W. (2019) · Brain Research · doi:10.1016/j.brainres.2019.01.005 · Cited by 94
Is Alzheimer’s disease an inflammasomopathy?
Pereira, C., Santos, A. E., Moreira, P. I., Pereira, A. C., Sousa, F. J., Cardoso, S. M., & Cruz, M. T. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100966 · Cited by 95
Electroacupuncture Alleviates Ischemic Brain Injury by Inhibiting the miR-223/NLRP3 Pathway
Sha, R., Zhang, B., Han, X., Peng, J., Zheng, C., Zhang, F., & Huang, X. (2019) · Medical Science Monitor · doi:10.12659/msm.917213 · Cited by 95
Бажанова, Е. Д., Kozlov, А. А., & Litovchenko, A. V. (2021) · Brain Sciences · doi:10.3390/brainsci11050663 · Cited by 98
Microglial Inflammasome Activation in Penetrating Ballistic-Like Brain Injury
Lee, S. W., Gajavelli, S., Spurlock, M. S., Andreoni, C. B., Vaccari, J. P. D. R., Bullock, M. R., Keane, R. W., & Dietrich, W. D. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5530 · Cited by 89
MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
Tezcan, G., Martynova, E. V., Gilazieva, Z., McIntyre, A., Rizvanov, A. A., & Khaiboullina, S. F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00451 · Cited by 89
NEK7 Regulates NLRP3 Inflammasome Activation and Neuroinflammation Post-traumatic Brain Injury
Chen, Y., Meng, J., Bi, F., Li, H., Chang, C., Ji, C., & Liu, W. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00202 · Cited by 85
Involvement of the hippocampus in chronic pain and depression
Mokhtari, T., Tu, Y., & Hu, L. (2019) · Brain Science Advances · doi:10.26599/bsa.2019.9050025 · Cited by 91
Kuwar, R., Rolfe, A., Di, L., Blevins, H., Xu, Y., Sun, X., Bloom, G. S., Zhang, S., & Sun, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210400 · Cited by 82
Acacetin protects against cerebral ischemia-reperfusion injury via the NLRP3 signaling pathway
Bu, J., Shi, S., Wang, H., Niu, X.-S., Zhao, Z., Wu, W., Zhang, X.-L., Ma, Z., Zhang, Y., Zhang, H., et al. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.247465 · Cited by 82
Litwiniuk, A., Bik, W., Kalisz, M., & Baranowska-Bik, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115603 · Cited by 82
Réus, G. Z., Fernandes, G. C., de Moura, A. B., da Silva, R. H., Darabas, A. C., de Souza, T. G., Abelaira, H. M., Carneiro, C., Wendhausen, D. L., Michels, M., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.08.020 · Cited by 84
Sun, Q., Wang, S., Chen, J., Cai, H., Huang, W., Zhang, Y., Wang, L., & Xing, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28907 · Cited by 82
Gao, C., Yan, Y., Chen, G., Wang, T., Luo, C., Zhang, M., Chen, X., & Tao, L. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00517 · Cited by 80
Cui, Y., Yu, H., Bu, Z., Wen, L., Yan, L.-L., & Feng, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.894298 · Cited by 80
Malko, P., Mortadza, S. A. S., McWilliam, J., & Jiang, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00239 · Cited by 79
Huang, M., Tu, C.-E., Wang, S., Hung, Y., Su, C., Fang, S., Chen, C., Liu, P., Cheng, W., Huang, Y., et al. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2287-5 · Cited by 78
The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury
Ishrat, T., Ismael, S., Ahmed, H. A., Adris, T., Parveen, K., & Thakor, P. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.286951 · Cited by 74
Zhang, L., Liu, H., Jia, L., Lyu, J., Sun, Y. J., Yu, H., Li, H., Liu, W., Weng, Y., & Yu, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3753485 · Cited by 74
Wang, H., Guo, Y., Qiao, Y., Zhang, J., & Jiang, P. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02071-5 · Cited by 72
The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases
Zhao, S., Li, X., Wang, J., & Wang, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.657478 · Cited by 72
TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Bright, F., Chan, G., van Hummel, A., Ittner, L. M., & Ke, Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157781 · Cited by 71
Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine
Erdener, Ş. E., Kaya, Ζ., & Dalkara, T. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01353-0 · Cited by 72
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
Barczuk, J., Siwecka, N., Lusa, W., Rozpędek‐Kamińska, W., Kucharska, E., & Majsterek, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168979 · Cited by 76
α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes
Ebrahimi, T., Rust, M. I., Kaiser, S., Slowik, A., Beyer, C., Koczulla, A. R., Schulz, J. B., Habib, P., & Bach, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1319-x · Cited by 72
The role of innate immunity in mucopolysaccharide diseases
Parker, H., & Bigger, B. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14632 · Cited by 72
MicroRNA targets and biomarker validation for diabetes-associated cardiac fibrosis
Jin, Z.-Q. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105941 · Cited by 69
Liu, F., Li, Z.-J., He, X., Yu, H.-Y., & Feng, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01320 · Cited by 65
The Role of NF-κB Triggered Inflammation in Cerebral Ischemia
Jover‐Mengual, T., Hwang, J.-Y., Byun, H.-R., Court-Vazquez, B. L., Centeno, J. M., Burguete, M. C., & Zukin, R. S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.633610 · Cited by 69
Muhammad, R. N., Ahmed, L. A., Abdelsalam, R. M., Ahmed, K. A., & Attia, A. S. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01140-4 · Cited by 70
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
Khan, M. B., Ai, M.-L., Du, K., Song, J., Wang, B., Lin, J., Ren, A., Chen, C., Huang, Z., Qiu, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1062225 · Cited by 70
Drożdżal, S., Rosik, J., Lechowicz, K., Machaj, F., Szostak, B., Majewski, P., Rotter, I., & Kotfis, K. (2020) · Brain Sciences · doi:10.3390/brainsci10070465 · Cited by 70
Serdar, M., Kempe, K., Herrmann, R., Picard, D. J., Remke, M., Herz, J., Bendix, I., Felderhoff‐Müser, U., & Sabir, H. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.540878 · Cited by 73
Mirzaei, F., Khazaei, M., Komaki, A., Amiri, I., & Jalili, C. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.04.064 · Cited by 70
Huang, Z., Zhou, X., Zhang, X., Huang, L., Sun, Y., Cheng, Z., Xu, W., Li, C. G., Zheng, Y., & Huang, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111814 · Cited by 66
Zong, C., Hasegawa, R., Urushitani, M., Zhang, L., Nagashima, D., Sakurai, T., Ichihara, S., Ohsako, S., & Ichihara, G. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02471-0 · Cited by 64
Metadata
- Authors
- Song, L., Pei, L., Yao, S., Wu, Y., & Shang, Y.
- Affiliations
- Wuhan Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Corresponding author
- Wu, Yan
- Shang, You
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-03-09
- Volume
- 11
- Pages
- 63-63
- ISSN
- 1662-5102 (ISSN-L)
- PMC
- PMC5343070
- OpenAlex
- W2591960163
- Cited by
- 467
- References
- 255
- Citations by year
- 2026: 29 · 2025: 42 · 2024: 52 · 2023: 66 · 2022: 60 · 2021: 74 · 2020: 51 · 2019: 41 · 2018: 35 · 2017: 13
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Cellular Neuroscience (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81270018, 81471202, 81271270)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, neuroinflammation, neurological disorders, caspase-1, IL-1β, IL-18, neurodegenerative diseases, brain infection, acute brain injury, NLRP3 inhibitors, anti-IL-1 therapy, conditional knockout mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review